The feasibility of onsite primary care services and their use by human immunodeficiency virus HIV-seropositive and seronegative injecting drug users within an outpatient methadone maintenance program are examined.
A 16-month prospective study was conducted within an ongoing cohort study of HIV infection at a New York City methadone program with onsite primary care services.
The study group consisted of 212 seropositive and 264 seronegative drug injectors.
A computerized medical encounter data base, with frequencies of primary care visits and with diagnoses for each visit, was linked to the cohort study data base that contained information on patients' demographic characteristics, serologic status, and CD4+ T-lymphocyte counts.
Mots-clés Pascal : Toxicomanie, Immunopathologie, Traitement, New York, Etats Unis, Amérique du Nord, Amérique, Voie intraveineuse, Immunodéficit acquis syndrome, Virose, Infection, Hémopathie, Méthadone, Accessibilité, Utilisation, Analgésique narcotique, Ambulatoire, Homme, Organisation santé, Service santé, Soin santé primaire
Mots-clés Pascal anglais : Drug addiction, Immunopathology, Treatment, New York, United States, North America, America, Intravenous administration, AIDS, Viral disease, Infection, Hemopathy, Accessibility, Use, Narcotic analgesic, Ambulatory, Human, Public health organization, Health service, Primary health care
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0600361
Code Inist : 002B30A01B. Création : 199406.